WOLVERINE TRADING, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$487,475
-75.4%
42,500
-47.0%
0.00%
-100.0%
Q2 2023$1,982,076
+50066.4%
80,246
-36.8%
0.00%
-50.0%
Q1 2023$3,951
+141.9%
126,933
+43.5%
0.01%
+200.0%
Q4 2022$1,633
-99.9%
88,447
-14.2%
0.00%
-33.3%
Q3 2022$2,646,000
+793.9%
103,091
+395.6%
0.00%
Q2 2022$296,000
-8.1%
20,800
+6.7%
0.00%
Q4 2021$322,000
-55.0%
19,500
-24.4%
0.00%
-100.0%
Q3 2021$715,000
+69.0%
25,800
+69.7%
0.00%0.0%
Q1 2021$423,000
-10.0%
15,200
-16.9%
0.00%0.0%
Q3 2020$470,000
-5.8%
18,300
-6.2%
0.00%0.0%
Q2 2020$499,000
+224.0%
19,500
+95.0%
0.00%
Q1 2020$154,000
-69.9%
10,000
-68.6%
0.00%
-100.0%
Q4 2019$512,000
-18.9%
31,800
-30.6%
0.00%
-33.3%
Q3 2019$631,000
+20.0%
45,796
+12.9%
0.00%
+50.0%
Q2 2019$526,000
+42.2%
40,564
+72.6%
0.00%0.0%
Q1 2019$370,000
-52.7%
23,500
-41.7%
0.00%
-33.3%
Q4 2018$783,000
-30.2%
40,342
-10.6%
0.00%0.0%
Q3 2018$1,121,000
+11.7%
45,143
+38.5%
0.00%0.0%
Q2 2018$1,004,0000.0%32,6000.0%0.00%0.0%
Q1 2018$1,004,000
-54.4%
32,600
-47.1%
0.00%
-62.5%
Q4 2017$2,204,000
+397.5%
61,637
+264.7%
0.01%
+300.0%
Q2 2017$443,000
+56.5%
16,900
+20.7%
0.00%0.0%
Q1 2017$283,000
-19.1%
14,000
-17.2%
0.00%0.0%
Q4 2016$350,00016,9000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders